The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZOE.L Regulatory News (ZOE)

  • There is currently no data for ZOE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Novel Food Application

6 Apr 2021 07:00

RNS Number : 4600U
Zoetic International PLC
06 April 2021
 

For immediate release

6 April 2021

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310

 

Zoetic International plc

('Zoetic', the 'Company' or the 'Group')

 

Zoetic's Novel Food Application passes FSA administrative check

 

Zoetic, the international CBD group, is pleased to provide the following update on its efforts to gain regulatory approval by the UK Food Standards Agency ('FSA' or the 'Agency') for its products in the United Kingdom. This FSA approval is now required for CBD products to be sold in the UK. This applies to all CBD brands and not only those owned by Zoetic.

 

Overview

· The FSA announced on 13 February 2020 that businesses must submit a novel food authorisation application by 31 March 2021 if they wish to have their CBD products sold in the UK. CBD products without the authorisation and subsequent validation would not be allowed to be sold in the UK.

 

· Zoetic submitted an application in conjunction with the European Industrial Hemp Association's ('EIHA') Novel Food Consortium.

 

· Zoetic received notification from EIHA that its CBD products passed the regulator's administrative check and can remain on sale in the UK.

 

· Official validation will be granted pending the results of toxicological studies on CBD, expected in the coming months.

 

Following the submission of a legal dossier, made in partnership with the EIHA's Novel Food Consortium, the Group has now received confirmation that its natural isolate CBD products can continue to be sold in the UK as the application has passed the regulator's administrative check. Official validation is expected to follow in the coming months, pending the results of toxicological studies of the CBD contained in its products.

 

Trevor Taylor, Co-CEO of Zoetic, said: "The FSA's regulation marks a pivotal moment for the CBD industry and Zoetic welcomes the Agency's efforts to protect consumers from CBD products that do not meet the necessary standards. We submitted our application with EIHA, a highly respected European industry association, and are thrilled that the submission has passed the initial check and we are now one step closer to full validation. As always, we are committed to rigorous quality assurance processes at every step because our success as a company is indivisible from the quality of our products."

 

Further progress is expected in the coming months. More information can be found on the EIHA website.

 

- Ends -

 

About the European Industrial Hemp Association

The European Industrial Hemp Association ('EIHA') represents the collective interests of key stakeholders in the hemp industry across the European Union ('EU'). Their primary function is to advocate for the industry by contributing to international policy-making consultations and decisions by European regulators. EIHA also operates a Novel Food Consortium which aims to secure the necessary regulatory approvals for members to continue producing and selling their products.

 

Publication on website

 

A copy of this announcement is also available on the Group's website at www.zoeticinternational.com

 

Media enquiries:

Zoetic International plc

c/o Buchanan

Trevor Taylor, Co-CEO

Antonio Russo, Co-CEO

 

 

Allenby Capital Limited (Financial Adviser and Broker)

+44 (0) 20 3328 5656

Nick Harriss (Corporate Finance)

 

Nick Naylor (Corporate Finance)

 

Guy McDougall (Equity Sales)

 

 

 

Buchanan

 

Henry Harrison-Topham / Jamie Hooper / Ariadna Peretz

Tel: +44 (0) 20 7466 5000

zoetic@buchanan.uk.com

www.buchanan.uk.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDKPBDDBKBKQK
Date   Source Headline
24th Nov 20209:00 amRNSPrice Monitoring Extension
24th Nov 20207:00 amRNSLandmark agreement to distribute products
19th Nov 20207:00 amRNSTrading Update
16th Nov 202011:06 amRNSSecond Price Monitoring Extn
16th Nov 202011:00 amRNSPrice Monitoring Extension
16th Nov 20209:05 amRNSSecond Price Monitoring Extn
16th Nov 20209:00 amRNSPrice Monitoring Extension
16th Nov 20207:00 amRNSUpdate on Director Share Purchases
13th Nov 20204:41 pmRNSSecond Price Monitoring Extn
13th Nov 20204:36 pmRNSPrice Monitoring Extension
5th Nov 20207:00 amRNSUpdate on Sale of DTU and Kansas Nitrogen Assets
29th Oct 20207:00 amRNSHolding(s) in Company
28th Oct 20204:00 pmRNSDirectors’ Share Purchases and Share Options
28th Oct 20203:30 pmRNSResult of AGM
28th Oct 20201:30 pmRNSExercise of Share Options
28th Oct 20207:00 amRNSTrading Update
21st Oct 202011:00 amRNSHolding(s) in Company
12th Oct 20204:40 pmRNSSecond Price Monitoring Extn
12th Oct 20204:35 pmRNSPrice Monitoring Extension
9th Oct 202011:05 amRNSSecond Price Monitoring Extn
9th Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 20207:00 amRNSNotice of AGM & Investor Presentation
1st Oct 20204:40 pmRNSSecond Price Monitoring Extn
1st Oct 20204:35 pmRNSPrice Monitoring Extension
30th Sep 20205:40 pmRNSFinal Results for the year ended 31 March 2020
30th Sep 20207:00 amRNSPreliminary Results for the year to 31 March 2020
16th Sep 202010:35 amRNSHolding(s) in Company
11th Sep 20202:05 pmRNSSecond Price Monitoring Extn
11th Sep 20202:00 pmRNSPrice Monitoring Extension
10th Sep 20207:30 amRNSSecond International Distribution Contract Signed
2nd Sep 20207:00 amRNSSale of Colorado Oil and Gas Interests
20th Aug 20204:41 pmRNSSecond Price Monitoring Extn
20th Aug 20204:35 pmRNSPrice Monitoring Extension
20th Aug 20202:00 pmRNSHolding(s) in Company
18th Aug 20202:05 pmRNSSecond Price Monitoring Extn
18th Aug 20202:01 pmRNSPrice Monitoring Extension
17th Aug 20205:30 pmRNSHolding(s) in Company
14th Aug 20202:30 pmRNSHolding(s) in Company
7th Aug 20203:02 pmRNSHolding(s) in Company
7th Aug 20202:05 pmRNSSecond Price Monitoring Extn
7th Aug 20202:00 pmRNSPrice Monitoring Extension
6th Aug 202011:05 amRNSSecond Price Monitoring Extn
6th Aug 202011:00 amRNSPrice Monitoring Extension
5th Aug 20204:00 pmRNSHolding(s) in Company
3rd Aug 20207:00 amRNSUpdate on Sale of DTU and Kansas Nitrogen Assets
23rd Jul 20202:32 pmRNSHolding(s) in Company
22nd Jul 20207:00 amRNSHemp Seed Update
8th Jul 20207:00 amRNSUpdate on Sale of DTU & Kansas Nitrogen Assets
6th Jul 20207:00 amRNSFirst International Distribution Contract
30th Jun 20206:00 pmRNSTotal Voting Rights & Reporting Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.